Date：29 July (Friday)
Time: 12:20 – 13:50 (GMT+8)
Medical Strategy Director
IQVIA RDS PTY. LIMITED
The 2020s were always going to be the era when the full commercial promise of cell, gene and RNA therapies, known collectively as advanced therapies, was to be realised and the pandemic, by hugely accelerating the development and uptake of mRNA vaccines, has been transformative for RNA.
We are at a pivotal moment in the development of these therapies; the next decade will bring enormous changes to usher cell, gene and RNA therapies into the pharmacotherapeutic mainstream.